Assessment of Screening Tools to Identify Substance Use Disorders Among Adolescents
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.14422
Abstract: Key Points Question Do existing screening tools, such as the Screening to Brief Intervention (S2BI), Brief Screener for Tobacco, Alcohol, and Drugs (BSTAD), and Tobacco, Alcohol, Prescription Medication, and Other Substances (TAPS), accurately identify substance… read more here.
Keywords: identify substance; substance use; disorders among; screening tools ... See more keywords
Estimating the Prevalence of Substance Use Disorders in the US Using the Benchmark Multiplier Method.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA psychiatry"
DOI: 10.1001/jamapsychiatry.2022.2756
Abstract: Importance Prevalence estimates of substance use disorders in the US rely on general population surveys. However, major population groups, such as homeless individuals and institutionalized individuals, are not captured by these surveys, and participants may… read more here.
Keywords: prevalence; substance use; benchmark multiplier; use ... See more keywords
Journey to wellness: A socioecological analysis of veterans in recovery from substance use disorders.
Sign Up to like & getrecommendations! Published in 2022 at "American journal of community psychology"
DOI: 10.1002/ajcp.12615
Abstract: Substance use disorders are increasingly prevalent among veterans in the United States. Veterans in recovery face unique challenges, such as high rates of psychiatric comorbidities, difficulties adjusting to civilian life, and inadequate housing and mental… read more here.
Keywords: use disorders; veterans recovery; substance use; recovery ... See more keywords
The therapeutic effect of N‐acetylcysteine as an add‐on to methadone maintenance therapy medication in outpatients with substance use disorders: A randomized, double‐blind, placebo‐controlled clinical trial
Sign Up to like & getrecommendations! Published in 2022 at "Brain and Behavior"
DOI: 10.1002/brb3.2823
Abstract: Patients with substance use disorders (SUD) under methadone maintenance therapy (MMT) are susceptible to a number of complications (psychological and metabolic disorders). Evidence studies have shown the roles of the glutamatergic system in addiction. N‐Acetylcysteine… read more here.
Keywords: use disorders; maintenance therapy; methadone maintenance; substance use ... See more keywords
Depression care among depressed adults with and without comorbid substance use disorders in the United States
Sign Up to like & getrecommendations! Published in 2017 at "Depression and Anxiety"
DOI: 10.1002/da.22592
Abstract: We compared the prevalence of receiving depression care between adults with past‐year major depressive episodes (depressed) and substance use disorders (SUD) in the United States and their depressed counterparts without SUD. read more here.
Keywords: depression care; united states; use disorders; substance use ... See more keywords
Effectiveness of a psychological intervention delivered by general nurses for alcohol use disorders in people living with HIV in Zimbabwe: a cluster randomized controlled trial
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the International AIDS Society"
DOI: 10.1002/jia2.25641
Abstract: There have been very few randomized clinical trials of interventions for alcohol use disorders (AUD) in people living with HIV (PLWH) in African countries. This is despite the fact that alcohol use is one of… read more here.
Keywords: effectiveness psychological; use; living hiv; people living ... See more keywords
Risk factors for cannabis use disorders and cannabis psychosis in Japan: Second report of a survey on cannabis‐related health problems among community cannabis users using social networking services
Sign Up to like & getrecommendations! Published in 2022 at "Neuropsychopharmacology Reports"
DOI: 10.1002/npr2.12307
Abstract: To determine the risk factors for cannabis use disorders and cannabis psychosis in Japan based on a 2021 online survey among Japanese users of social network services. read more here.
Keywords: disorders cannabis; factors cannabis; cannabis psychosis; risk factors ... See more keywords
Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France
Sign Up to like & getrecommendations! Published in 2018 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.4635
Abstract: Baclofen is widely used off‐label for alcohol use disorders (AUD) in France, despite its uncertain efficacy and safety, particularly at high doses. This study was designed to evaluate the safety of this off‐label use compared… read more here.
Keywords: baclofen; use disorders; use; alcohol use ... See more keywords
Increased risk for COVID‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021
Sign Up to like & getrecommendations! Published in 2021 at "World Psychiatry"
DOI: 10.1002/wps.20921
Abstract: Individuals with substance use disorders (SUDs) are at increased risk for COVID‐19 infection and for adverse outcomes of the infection. Though vaccines are highly effective against COVID‐19, their effectiveness in individuals with SUDs might be… read more here.
Keywords: risk; use disorders; fully vaccinated; infection ... See more keywords
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Sign Up to like & getrecommendations! Published in 2023 at "World Psychiatry"
DOI: 10.1002/wps.21073
Abstract: Substance use disorders (SUDs) are highly prevalent and exact a large toll on individuals’ health, well‐being, and social functioning. Long‐lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and self‐awareness underlie… read more here.
Keywords: neurobiology; substance use; epidemiology; use ... See more keywords
Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol.
Sign Up to like & getrecommendations! Published in 2018 at "Handbook of experimental pharmacology"
DOI: 10.1007/164_2018_100
Abstract: Understanding the neural systems that drive alcohol motivation and are disrupted in alcohol use disorders is of critical importance in developing novel treatments. The dynorphin and orexin/hypocretin neuropeptide systems are particularly relevant with respect to… read more here.
Keywords: neuropeptide systems; dynorphin orexin; alcohol; alcohol use ... See more keywords